Halitosis is receiving increasing scientific interest, but still no accepted definition exists. In the literature, definitions include: 'the subjective perception after smelling someone's breath, if unpleasant', 1 'noticeably unpleasant odours exhaled in breathing', 2 'an oral health condition characterised by unpleasant odours emanating consistently from oral cavity', 3 'general term to describe any disagreeable odour of breath, regardless of its origin', 4 and 'an unpleasant odour emanating from oral cavity. ' 5 Many definitions are inadequate, ignoring the potential emanation of odours via the mouth and nose from the respiratory and gastroesophageal tracts, transfer of volatiles from blood to breath during alveolar gas exchange, and also self-perception of halitosis by the patient. To varying degrees the breath always has odorant volatiles, originating orally or elsewhere. None set a clear boundary between normal, physiologic breath odour and, pathologic halitosis. Negative identification of an odour requires qualification. Who determines this? The patient, the patient's social environment, Background There is no universally accepted, precise definition, nor standardisation in terminology and classification of halitosis. Objective To propose a new definition, free from subjective descriptions (faecal, fish odour, etc), one-time sulphide detector readings and organoleptic estimation of odour levels, and excludes temporary exogenous odours (for example, from dietary sources). Some terms previously used in the literature are revised. Results A new aetiologic classification is proposed, dividing pathologic halitosis into Type 1 (oral), Type 2 (airway), Type 3 (gastroesophageal), Type 4 (blood-borne) and Type 5 (subjective). In reality, any halitosis complaint is potentially the sum of these types in any combination, superimposed on the Type 0 (physiologic odour) present in health. Conclusion This system allows for multiple diagnoses in the same patient, reflecting the multifactorial nature of the complaint. It represents the most accurate model to understand halitosis and forms an efficient and logical basis for clinical management of the complaint.
to North American society with regards to halitophobia, and appeared in publications a decade ago. [7] [8] [9] This classification is inflexible since multiple diagnoses for one patient are not enabled. The broad category 'extraoral, pathologic halitosis' does not aid referral choice or help the receiving clinician, and is also poor for researchers who need to precisely classify extra-oral halitosis according to aetiology. 'Morning breath' is not placed in the oral category, despite manifesting orally. Inappropriately, two out of three categories (pseudo-halitosis and halitophobia) have psychopathologic connotations and they are excluded from pathologic halitosis. Subjective halitosis can be caused by psychologic or neurologic factors, which are technically extra-oral processes, yet 'extra-oral halitosis' is again excluded from pathologic halitosis. After treatment, whether for genuine halitosis or pseudohalitosis, if the patients continue to believe they have halitosis, reclassification to halitophobia occurs. This categorises cases according to treatment outcome, as halitophobia is diagnosed following a failed treatment. This scheme claims to provide treatment needs, but how can these be determined beforehand if they depend on results of treatment? Pseudo-halitosis is misleading when considered alongside other medical terms, for example, pseudo-Cushing's syndrome, intestinal pseudo-obstruction, pseudo-lymphoma or pseudo-Kaposi's sarcoma. These exist as physical entities that masquerade as their namesake. Pseudo-halitosis implies a genuine, physical condition mistaken for non-existent halitosis. Similarly, halitophobia suggests an irrational fear, but instead refers to where the patients believe their treatment unsuccessful.
Tangerman and Winkel suggest intra-and extra-oral halitosis, the latter then divided into non-blood-borne and blood-borne. 10 An earlier publication divides extra-oral halitosis into blood-borne, upper respiratory tract and lower respiratory tract. 11 They list four aetiologic mechanisms of blood-borne halitosis: systemic diseases, metabolic disorders, food and medications. 10 These authors use 'pseudo-halitosis/halitophobia' to describe no measurable halitosis, while retaining their own classification for measurable halitosis. 12 In reality, this classification focuses on oral and blood-borne halitosis, with insufficient categorisation of physiologic, sinonasal, laryngopharyngeal, gastroesophageal or psychologic causes. The significance of blood-borne halitosis relative to other extra-oral mechanisms is unclear and a broad division into blood-borne and non-blood-borne may be inappropriate. Again, this system does not allow for multiple diagnoses, making accurate categorisation of some cases difficult, and there is no distinction between pathologic and physiologic halitosis.
Motta et al. suggest primary halitosis ('respiration exhaled by the lungs'), and secondary halitosis ('originates in mouth or upper airways'). 13 It is unclear if primary halitosis refers to blood-borne halitosis, odour from the lower respiratory tract itself, or both. This is seldom used, perhaps because the clinical utility is limited by not addressing subjective halitosis or gastroesophageal halitosis.
Previous terminology
In some cases, odour is not detected organoleptically and volatile sulphur compound (VSC) levels are normal. There is no local or systemic condition and no reliable, third party confidants confirming the complaint. This scenario is generally ascribed to psychologic factors, termed imaginary halitosis, 14 delusional halitosis, 15 pseudo-halitosis, 7 non-genuine halitosis, 16, 17 chronic olfactory paranoid syndrome, 18 anthropophobia (taijin kyofusho), 19 halitophobia, 20 olfactory reference syndrome (ORS), 21, 22 and social anxiety disorder. 23 These terms may easily cause confusion.
The term psychosomatic halitosis is incorrectly used when referring to subjective halitosis complaints. Psychosomatic disorders are disorders in which psychologic factors play a significant role and there are physical symptoms that are detectable clinically. However, the term psychosomatic halitosis is used to describe an odour is that is clinically non-existent.
Terms that refer to odour character promote confusion for clinicians and patients, for example sulphurous/faecal, fruity, and ammoniacal/urine-like; respectively attributed to VSC, acetone, and ammonia with other amines. 10 Sweet, musty or fishy are used to describe particular halitosis types. However, fish odour is nonspecific for trimethylaminuria (TMAU), 24 as is acetone for diabetes. All individuals have detectable breath acetone >400 ppb, 25, 26 especially when fasting. Fish odour can be perceived as musty and acetone as sweet. The sweet, musty aroma in liver failure has been termed fetor hepaticus. 27 This is also described as faecal, 'the smell of dead mice' or 'the breath of the dead' . 28 Other terms include 'denture odour', 29 'uraemic fetor' in renal failure, 30 and 'rotten egg' in poor oral hygiene. All these terms are subjective and open to misinterpretation. There is no standardisation in terminology, which has led to discrepancies developing where some authors use a term with one definition and others with different meaning.
• Oral malodour, oral halitosis, tongue malodour, odontogenic halitosis, pathological halitosis, objective halitosis, genuine halitosis and intra-oral halitosis are used incorrectly as synonyms for halitosis. 31 For example, oral malodour includes all odours originating orally, not just the tongue; but not all pathologic/ objective halitosis originates orally • Pseudo-halitosis, psychosomatic halitosis, halitophobia, self-halitosis, imaginary halitosis non-genuine halitosis, delusional halitosis and phantom halitosis are also sometimes used interchangeably, 32 but they not synonymous, for example, halitophobia describes a fear; self-halitosis describes clinically existent, self-producing odour; imaginary halitosis describes halitosis produced psychologically; and phantom halitosis is neurologic • Morning breath is sometimes used instead of physiologic halitosis, but these are also dissimilar. Not all 'morning breath' is physiologic. 
NEW DEFINITION OF HALITOSIS

Type 0 halitosis: physiologic halitosis
Type 0 halitosis represents the sum of the physiologic contributions of oral, airway, gastroesophageal, blood-borne and subjective halitosis that are potentially present in every healthy person, in any combination. All healthy individuals have a certain level of bacterial activity in the mouth and on respiratory tract mucosae. In addition there is a potentially a negligible amount of gas leakage from the gastroesophageal tract, and blood gases are transferred to the exhaled breath during gas exchange in pulmonary alveoli. Therefore, minimal amounts of Types 1-5 potentially exist in health. The total level of odour and the relative contributions of these different sources of physiologic odour is subject to both interpersonal variation, and also variation in the same individual from one occasion to the next. One or multiple types may exist in any combination at any time, varying according to many different factors, including hydration, oral hygiene, microbiota, salivary flow rate, nature of last food consumption, biochemical, hormonal, mechanic activity of the body, fasting, sleep, digestive enzyme profile in gut, momentarily amino acid and electrolyte profile in serum etc. It is distinguished from oral halitosis ( Table 1) .
Type 1 halitosis: oral halitosis
The gases that contribute to Type 1 (oral) halitosis are (greatest to least): VSC, volatile organic compounds (VOC) and nitrogen containing gases (amines). 33 The main VSC involved are hydrogen sulphide (H 2 S), methyl sulphide (CH 3 SH, or methyl mercaptan, MM), and dimethyl sulphide [(CH 3 ) 2 S, DMS]. Nearly 700 different compounds have been detected orally, 34 including indole, skatole, acetic acid and short chain acids (for example, butyric, valeric, isovaleric, lactic, caproic, propionic and succinic acids). In halitosis patients, the 30 most abundant VOC in mouth air are alkanes or alkane derivatives, and of these the most common are methyl benzene, tetramethyl butane, and ethanol. 35 Alkanes are aromatic breakdown products from reactive oxygen species acting on inflamed tissues. 35 Others report acetone, methenamine, isoprene, phenol, and D-limonene are the most abundant organic compounds in mouth air in oral halitosis patients. The organoleptic level of oral halitosis correlates with VSC, 34 and amines (such as putrescine, cadaverine, and trimethylamine). 36 The gases responsible for oral halitosis are by-products of protein and glycoprotein putrefaction by the oral microbiota. The dorso-posterior tongue is the most important halitogenic site, by virtue of having both the largest surface area and the highest bacterial load, within a densely populated biofilm. [37] [38] [39] About 85% of oral halitosis cases are caused by poor oral hygiene, plaque stagnation areas, gingivitis, and tongue coating. 31 However, a degree of oral bacterial action is continuously present in health, even with impeccable oral hygiene, and this constitutes the physiologic part of Type 1 halitosis.
Specific bacteria, especially anaerobes, are suggested to cause oral halitosis. 40, 41 In reality, most oral bacteria are potentially Other possible origins of oral halitosis include: periodontal disease, acute necrotising ulcerative gingivitis, osteoradionecrosis, large carious cavities, blood/thrombi (for example, extraction sockets), ulceration, interdental food packing, oral prostheses (dentures, orthodontic appliances, bridges).
Type 2 halitosis: airway halitosis
Type 2 halitosis originates from the respiratory tract itself (rhinosinusitis, tonsillitis, pharyngitis, laryngitis, bronchitis, pneumonia), anywhere from nose to alveoli. Odorous gases produced by various respiratory pathoses are held in the exhaled breath and expressed via the nose or mouth. This should be distinguished from Type 4 (blood-borne) halitosis, where volatiles from the systemic circulation are transferred during gas exchange to the breath. Some studies report the proportion of halitosis cases that are due to upper respiratory tract pathology to be between 2.9 and 10%. 31, [43] [44] [45] [46] [47] Halitosis is considered a regional symptom of chronic rhinosinusitis, and some report as many as 50-70% will complain of halitosis. 48, 49 In paediatric patients, one of most frequent symptoms is halitosis together with cough, rhinorrhoea and sniffling, 50 even when nasal obstruction, post-nasal exudate, pain, sneezing and secretion are clinically absent. 51 Sinonasal anatomic variations (for example, agger nasi cells, pneumatisation of turbinates or septum; deviated nasal septum) are very commonly found together with mucosal pathoses including rhinosinusitis. 52 Post nasal drip is where mucus drains onto the dorsal tongue via the nasopharynx. 53 This is related to allergic rhinitis, however, the existence of post-nasal drip as a clinical entity is disputed as this occurs in health and there is no agreed definition or pathologic changes. 54 Mucus stagnation provides a proteinaceous medium for more bacterial putrefaction, but the relationship between halitosis and post-nasal drip has not been formally investigated.
Obstructive nasal pathology causes mouthbreathing, possibly resulting in xerostomia and halitosis. 13, 55 Tonsillitis causes oedema and hypertrophy, which may obstruct orifices on tonsillar surface. This disrupts the cleansing flow of secretions, and desquamated epithelial and bacterial cells, extracellular matrix and food debris become trapped, leading to stagnation. Bacteria putrefy local substrate and release VOC and VSC, expressed on the breath as halitosis with a similar mechanism that operates on the tongue surface. Crypt debris may mineralise, similar to the transformation of dental plaque to dental calculus. These mineralised deposits are termed tonsilloliths (tonsil stones). The presence of tonsilloliths is strongly associated with abnormal VSC levels. 46 They are asymptomatically present in up to 10% of the general population. 56 Anaerobic bacteria detected in tonsilloliths include Eubacterium, Fusobacterium, Porphyromonas, Prevotella, Selenomonas and Tanerella spp., all associated with the production of VSCs. 57 Odorous gases from the mouth or present in oronasal secretions can excite olfactory receptors and be perceived as halitosis, 58 even if no halitosis can be detected halitometrically. This is retronasal olfaction and is usually misdiagnosed.
'Airway reflux' describes gaseous or liquid gastric contents refluxing to the pharynx, oral cavity, nasal cavity, paranasal sinuses or even the middle ear, 59 and is sometimes said to be a cause of halitosis, however, there is little credible evidence for this mechanism.
Other respiratory tract causes of halitosis include: laryngitis, tracheitis, bronchitis, bronchiectasis, pneumonia, tuberculosis, nasal foreign bodies, rhinoliths, atrophic rhinitis (ozena), abscesses (peritonsillar, nasopharnygeal, lung), and carcinomas (nasal, sinuses, pharyngeal, lung).
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Type 3 halitosis: gastroesophageal halitosis
Type 3 halitosis is leakage of odorant volatiles from the stomach via the oesophagus to the mouth and nose. This should be distinguished from volatiles in the GI tract being absorbed into the systemic circulation and exhaled (Type 4, blood-borne halitosis). A degree of gastroesophageal reflux is considered normal, occurring in almost all individuals several times per day. 66 In a study of 14 healthy individuals, 1.2 ml/10 min gas leakage from the stomach to the oesophagus while lying horizontal and 6.8 ml/10 min while sitting was demonstrated. 67 If odorous, this constitutes the physiologic part of gastroesophageal halitosis.
Pathologic level of gastroesophageal halitosis is said to occur due to i) gastroesophageal reflux disease (GERD), ii) Helicobacter pylori related gastritis, or iii) other causes for example, gastrocolic fistulae, Zenker diverticulum and hypopharyngeal diverticulae. 66 Falcao et al. argued that certain GI disorders can cause taste disturbance. Taste receptor cells are associated with lingual papillae, but also present on the palate, epiglottis and upper oesophagus. Low intensity acid reflux can cause phantom taste sensations, which may manifest as subjective halitosis. 16 Evidence for GERD-related halitosis is contradictory. Some studies report selfreported/subjective halitosis complaints are associated with GERD. [68] [69] [70] [71] One study reported gastroesophageal pathology in less than 50% of patients complaining of halitosis, 72 while others report that GI disorders may account for up to 5% of objective halitosis complaints. 31 A systematic review investigated the relationship between GERD and halitosis (among other things). Three studies were included, and the authors concluded halitosis is a possible extraoesophageal symptom of GERD, 73 however, two of these studies utilised questionnaires (that is, subjective halitosis). Yoo et al. report H. pylori infection correlated with elevated VSC in mouth and mucosal erosions, 74 posing halitosis as a potential biomarker to distinguish between erosive (200 ppb) and (75 ppb) non-erosive GERD. 75 Gas chromatography on gastric juice and biopsies in these subjects found resolved 7.5 ppm significantly higher H 2 S and expression of VSC-releasing enzymatic activity in the erosive group, and 0.5 ppm in the non-erosive group. 74 However, another study reported no significant difference in halitosis parameters when comparing erosive and nonerosive GERD. 76 Others have suggested the stomach rarely causes halitosis 10 and gastroscopy in halitosis patients is entirely unnecessary, 12 as the findings do not correlate with halitosis. 77 It has also been argued that there is no evidence that odorous substances are formed in the stomach. 12 Another study reported no statistically significant difference in the prevalence of halitosis symptoms between children with GERD and those without. 78 H. pylori infection also has a controversial role. H pylori possesses a strain-dependent ability to synthesise H 2 S and MM from combined cysteine-methionine substrate in vitro. 79 Elevated levels of both hydrogen cyanide and hydrogen nitrate were detected on the breath of H. pylori infected patients compared to healthy controls; 80 however, whether this represents Type 3 or Type 4 (blood-borne) halitosis is unknown.
Oral H. pylori colonisation without gastritis may cause Type 1 (oral) halitosis. PCR detected H. pylori in 6.4% (21/326) of saliva samples from non-dyspeptic individuals complaining of halitosis. H. pylori was associated with higher MM concentration. 81 Improvements in halitosis (defined by various methodologies) following eradication therapy are reported. [82] [83] [84] [85] [86] [87] Positive correlation between H. pylori and halitosis is reported by some studies, [88] [89] [90] however, some of these can be criticised for relying on self-reported halitosis rather than semi-objective breath analysis. 91 Others report no statistically significant correlation. 69, 77, [91] [92] [93] This mechanism is rarely responsible for halitosis, but cannot presently be dismissed due to several studies that support the idea that GI disease may cause halitosis.
Type 4 halitosis: blood-borne halitosis
Type 4 (blood-borne) halitosis is where volatile chemicals in the systemic circulation can transfer to exhaled breath during alveolar gas exchange and cause halitosis. 94 Volatiles are endogenously produced, mostly by-products of biochemical metabolic processes. 11 The concentration of volatiles on the exhaled breath reflects their respective arterial concentrations. 24 Healthy subjects' breath contains 3,481 VOCs, 95 constituting the phsyologic aspect of Type 4 halitosis ( Table 2) .
Methylated or low carbon containing alkanes, cyclic hydrocarbons, alcohols and aldehydes has an especially pungent odour when they exceed specific odour thresholds for the individual or his/her social environment, constituting pathologic Type 4 halitosis. The threshold concentration for any given chemical depends on the change in intensity (odour strength) with concentration and the odour character. There is also interpersonal variation in emotional reactions to detected odour; some may react positively and others negatively. 108 A single volatile chemical can be perceived at lower concentrations than expected when it is combined in a mixture of thousands of VOC like the breath by interaction with other odorants and collective stimulation of olfactory receptors.
Artificial systems containing chemical sensor arrays for the detection of breath volatiles allow for profile readings of multiple compounds instead of single sensors for a single volatile. 109 This is more favourable as breath odours are not limited to a single or a handful of gasses describable according to their individual threshold levels. Rather, breath odours are 'olfactory spectra' of breath. Every exhaled odorant gas should be suspected as potentially contributing, by varying degrees, to the overall perception of breath odour.
In pathologic Type 4 halitosis the concentrations and profile of exhaled gases is significantly different to those seen in health, depending on the pathology. Exhaled breath volatiles are reported in diabetes mellitus, sleep apnea, H. pylori infection, sickle cell disease, asthma, breast cancer, lung carcinoma, chronic obstructive pulmonary disease, cystic fibrosis, liver diseases, cirrhosis, uraemia, kidney failure and TMAU. 24, 94 Breath alkanes have a pungent odour and are elevated in intestinal inflammation, 110 for example, ulcerative colitis, 111, 112 Crohn's disease, 112 in pulmonary tuberculosis, 113 schizophrenia, 114 pneumonia, 115 asbestosrelated disorders, 116 stomach cancer, 117 and angina pectoris. 118 Pregnant females or preeclampsia patients have a specific breath gas profile, including undecane, 6-methyltridecane, 2-methylpentane, 5-methyltetradecane and 2-methylnonane. 119 DMS, acetone, 2-butanone and 2-pentanone are reported in liver failure, including cirrhosis. 27 The 'fetor hepaticus' of hepatic failure is largely caused by DMS, not ammonia. 28 Elevated blood DMS ('dimethylsulphidemia'), 28 was reported to be responsible for the majority of cases of blood borne halitosis. 12 Body odour may accompany Type 4 halitosis as the same volatiles are also excreted during perspiration. This is sometimes termed blood-borne body odour and halitosis. An example is TMAU, a rare condition, classically characterised by fish odour in urine, sweat and breath.
When odorous chemical in blood circulation exceeds a critical level then it is secreted to breath, urine, tear, saliva and sweat. In such conditions body odour appears. In other circumstances, breath odour (Type 4 halitosis) is detected without body odour.
Another potential blood-borne mechanism may contribute to a halitosis complaint when blood-borne odorants stimulate olfactory receptors via their blood supply. 16, 120 Strong olfactory receptor responses can be triggered by intravascular injection of odorants in tracheotomised animals. Such odour perceptions are not occurring by the normal air-borne route, so there may not be measurable halitosis.
Type 5 halitosis: subjective halitosis
Subjective halitosis is a halitosis complaint without objective confirmation of halitosis by others or halitometer readings. Type 5 halitosis can be misdiagnosed if there are measurement errors or transient symptoms. 106, 107 Along with methane, hydrogen is an indicator gas used in disaccharide malabsorption tests to detect intestinal gases exhaled in breath. 105 Odorous breath gases (Type 4 halitosis) are potentially present when breath hydrogen is elevated 33 It can be considered normal for even mentally healthy individuals to worry occasionally about to be having halitosis. 121 Such halitosis concern can be rationally dismissed by most healthy people who have a degree of psychological resilience that is capable of compensating for stressors. This normal level of concern for halitosis constitutes the 'physiologic' aspect of Type 5 halitosis.
Pathologic subjective halitosis can be categorised as psychologic or neurologic.
Psychologic causes
Psychologic factors can cause subjective halitosis. This is termed monosymptomatic hypochondriacal psychosis, 16 a type of obsessive-compulsive spectrum disorder, 121 or olfactory reference syndrome (ORS). Seventy-five percent of ORS patients present with halitosis complaints, 122 but obsession over other non-existent body odours, often in combination, are included. Others' behaviour (for example, opening windows, sniffing, touching noses etc) is misinterpreted as evidence of halitosis. Employment loss, divorce or suicidal ideation are reported. 123 'Doctor shopping' to find clinicians to treat the non-existent odour may occur. However, some report that TMAU or other genuine odour symptoms can be misdiagnosed as ORS. 124 It may be the case that the previously black and white thinking of objective halitosis on the one hand and psychologic halitosis on the other is an oversimplification. Instead, it might be more accurate to consider a spectrum, with entirely subjective halitosis at one extreme and entirely objective halitosis with no psychologic concern at the other. Most patients will fall somewhere between these two points.
When objective halitosis has not been treated it may cause the patient distress or social isolation and eventually over-concern about halitosis may develop. Even after the odour is reduced to physiologic levels, the negative psychosocial sequelae may persist, making these cases difficult to treat. Conversely, oversensitivity to physiologic odour may be the basis of a subjective halitosis with no history of objective halitosis.
Neurogenic causes
Traditionally, subjective halitosis complaints are attributed to psychologic factors, but at least some are neurologic. Nearly 200 disorders can cause chemosensory dysfunction (CSD). 16 Dysosmia (disordered olfaction including parosmia and phantosmia) and dysgeusia (disordered gustation) present extensive differential diagnoses.
Olfaction and gustation are intimately interlinked at the neuronal level in the brain. The definition of subjective halitosis (pseudo-halitosis) has been broadened: 'the perception of an alteration in the quality of expired odour air, a symptom perceived only by the patient. ' 16 Many patients fail to distinguish between bad taste and bad odour. Gustatory stimuli may influence orthonasal and retronasal odorant perception. 58 Side effects of medication, hypothyroidism, hyposalivation (another extensive differential), nutrient deficiency (zinc, copper, iron, and vitamins A and B12), trauma and tumours involving the olfactory centre in the brain, or nerve damage (glossopharyngeal, vagus, chorda tympani, olfactory), neurodegenerative diseases (Parkinson's, Alzheimer's and Huntington's disease), environmental pollutants (for example, smoking), drug abuse, certain oral hygiene products (for example, mouthwashes) and certain foodstuffs can all be potentially involved in subjective halitosis complaints by various mechanisms. 16, 125 As described previously, diabetes mellitus, GERD and blood-borne stimulation of taste and smell receptors via the blood circulation may also contribute to subjective halitosis. 16, 126 
NEW TERMINOLOGY
Unhelpful terms no longer needed:
• Many of the confusing array of synonyms used to describe a psychologic, subjective halitosis complaint (which would fall within Type 5 halitosis) are unneeded, including pseudo-halitosis, non-genuine halitosis, delusional halitosis, olfactory obsession, psico-olfactory sensitivity, olfactory depression, halitosis anxiety and imaginary halitosis • Subjective, descriptive terms such as sulphurous, ammoniacal, faecal, fishy or similar should be discontinued since they invite misunderstanding.
Useful terms that are retained:
• Objective halitosis refers to any combination of Types This mechanism is correctly termed psychosomatic, since a physical symptom is being influenced by psychologic factors. This is the uniquely correct usage of the term 'psychosomatic halitosis', rather than previous meanings (see 'Previous terminology') • Self-halitosis has been used to describe a lack of objective halitosis even though the patient believes themselves to have halitosis, 32 but it is better used to define endogenously produced, self-perceived odour, which is not a detectable odour to others. By true description, self-halitosis appears in three forms: retronasal olfaction, olfactory receptor responses triggered by blood-borne odorants, and phantom tastes/odours • Halitophobia should be retained with correct meaning. It refers to 'fear of having halitosis' but not 'untreated halitosis' .
New terms
• Exogenous odour results from consumption of aromatic foodstuffs (for example, garlic, onion, spicy foods), beverages (for example, alcohol) or tobacco. Exogenous volatiles may be released transiently from residues of food or drink in the mouth, or released unchanged via the blood-borne mechanism after being absorbed. Such odours are distinguished from pathologic halitosis, for example, garlic smells like garlic. The terms garlic odour, spice odour, etc seem suitable. Dietary or temporary halitosis are also terms that could be argued to be useful • Halitosis is an endogenous odour because it is produced in the body.
DISCUSSION
The new definition places less importance on organoleptic examination and single occasion halitometric reading, and instead places more emphasis on the declarations of the patient and his/her social environment. The reasoning for this follows.
Organoleptic examination
Organoleptic measurement is carried out by smelling the patient's breath then scoring the level of halitosis. 7 However, the examiner does not smell a pure sample of mouth air, but rather a mixture of mouth air and alveolar air. The organoleptic examination does not distinguish between these, only subjectively assesses the overall odour level.
The perception of odorants depends upon several factors, including constant fluctuations in the clinician's individual threshold level for that specific odour, what was last smelled before the examination, the concentration and volatility of the molecules themselves, room temperature (gases are less volatile in lower temperatures), humidity of exhaled breath, how strongly the breath is blown into the examiner's nose (less forcefully expired breath will consist of less volume of air, and less odorant molecules will be carried to the examiner's olfactory epithelia), and lastly the examiner's concentration at that moment. All these parameters vary from one hour to the next and from one individual to the next, making this a subjective measure that does not reflect the actual level of odour. It can be suggested that self-applied organoleptic scoring (self-assessment) should be evaluated to monitorise prognosis.
Organoleptic examination is problematic, 132 and objectionable to both dentists and to patients. Dislike or shame is experienced by 50% of patients with this examination (n = 283). 133 Some use a privacy screen to prevent the patient from seeing the examiner during the examination. 7 Examiners find it repulsive to smell a halitosis patient's breath.
Self-detection of halitosis correlated positively with actual halitosis only when subjects smelt their own saliva isolated from their mouth. Other methods did not correlate. 134 Another study reported less correlation between self-detection of halitosis and clinical findings. The sensitivity and specificity of self-perceived oral malodour were 47.2% and 59.2%, respectively. 135 The same author later compared 252 halitosis patients' self-estimation, organoleptic and halitometric results and found that selfestimated corresponded significantly with clinical oral malodour.
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Halitometers
Gas chromatography (GC), alone or combined with mass spectrometry (MS), is most frequently utilised for highly sensitive VSC detection (1-10 ppb). Nevertheless, routine application of these clinically is impractical given the expense and complexity, and the expertise required. 94 More practical methods utilise colorimetric hydrogen sulphide sensors engineered both as an optical fibre, capable of measuring reflectance change of an immobilized reagent, 137 and as thin reactive films of chromophores.
138
A bio-electronic nose capable of detecting the oxygen consumption induced by an enzymatic reaction with methyl sulphide has also been developed. 139 The Halimeter 140 contains an electrochemical sensor for VSC. The semiconductor gas sensors Breathtron, 141 constructed as a zinc oxide film with specificity to hydrogen sulphide and mercaptans.
142
The GC-based OralChroma, 143 is portable equipment capable of determining combined H 2 S, MM and DMS levels, with a 10 min response time and a detection limit of a few ppb. Twin Breasor, 144 Diamond Probe/Perio 2000, 145 Cyranose 320, 146 and B/B Checker, 147 are portable devices for detecting several gases including VSC and other odorous gases in mouth or breath air. 148, 149 Their accuracy is poor compared to GC and MS. They cannot distinguish one odour from another, and they have difficulty distinguishing individual compounds from the family of VSC. 132 Almost all halitosis researchers and specialists use portable sulphide monitors (for example, Halimeter) to detect oral VSC.
14 Good correlation exists between Halimeter readings and VSC concentration, 35 and sulphur-producing bacteria levels. 150 However, Halimeter readings are imprecise and misdiagnosis may result. 151 The Halimeter has biexponential response to a constant concentration of VSC. Rapid (peak) and slow (plateau) responses differed. The total VSC in air samples was 2.7 times greater than at its peak concentration, but its plateau phase measurement is 25% greater than the actual concentration. A modified protocol measuring plateau instead of peak values is available, yielding more favorable correlation with the actual level of VSC. 152 In order to investigate the Halimeter's ability to distinguish between VSC and other gases, having calibrated the Halimeter to ambient air, the aspirating tube was inserted into the headspace of some 250 ml commercial juice cartons immediately after opening. The Halimeter readings for apricot, apple, peach, cherry juices, buttermilk, soda, were 114, 352, 91, 48, 39, 47 ppb VSC respectively. In a similar experiment, the Halimeter reported VSC as if H 2 S is emitted from various flowers: daffodil, rose, jasmine were 255, 42, 73 ppb while 104 ppb was read near a sump, and 417 ppb near hand soap. When using another gas detector in the same conditions, all these flowers read with different percentages of VOC, not VSC. 153 Such simple experiments show that the Halimeter seems to confuse VSC with other odorants, and may not be selective enough for halitosis. The OralChroma gives more comprehensive VSC level readings than the Halimeter, 41 but it shares the VSC exclusivity limitation and therefore cannot fully determine the actual level of breath odour due to potential minor contributions from non-VSC gases.
New gas detectors capable of detecting sulphur and nitrogen containing gases, as well as VOCs should be developed for use in halitosis detection. There are industrial, portable gas detectors that are capable of detect more than four gas groups including VSC, NH 3 , or VOC that could potentially be utilised at one reading. A sensor system for monitoring the simple gases H 2 , CO, H 2 S, NH 3 , VOC and ethanol, 154 and breath test kits including instruments to detect breath H 2 and methane are available.
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Perturbation on threshold of halitosis
There is no consensus regarding what VSC reading corresponds to clinically present halitosis (Table 3) .
Besides these data, some describe ranges of VSC readings, eg: 0-40, healthy; 41-60, physiologic; 61-80, slight; 81-110, moderate; VSC thresholds should be revisited to improve clinical utility. 163 According to the new concepts described in this paper, there is no need to establish any precise VSC level that constitutes a halitosis diagnosis. Any patient complaining of halitosis is at least Type 5, even if objective halitosis is not diagnosed. Treatment should be targeted reducing pathologic halitosis to physiologic halitosis. Setting the goal at zero odour is unrealistic and arguably impossible.
There are three reasons to restrict the use of halitometers. Firstly, since baseline mouth air VSC concentrations fluctuate throughout day, 151 halitometric reading at any particular time may not be representative. For this reason, multiple halitometric examinations carried out at different times throughout the day may be more representative compared to a single occasion in the dental clinic. Or cysteine challenge, 164 should be applied to decide optimal VSC level of that individual.
Secondly, popular, portable halitometers are simply sulphide detectors, capable of detecting only VSC. However, nonsulphurous gases are also present in the mouth or breath, albeit in a lesser concentration than VSC. Halitometers are poor at distinguishing one odour from another. For example, in TMAU, the breath could be malodorous due to the presence of TMA and VSC levels may be under the normal range in such patients. Thus, examiners may misdiagnose some objective halitosis cases as if subjective halitosis by relying entirely on the specifity of halitometers.
Thirdly, there is no scientifically accepted quantitative threshold between physiologic odour and pathologic halitosis.
